Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD45RA-depleted haploidentical HPC and NK cell transplant for relapsed/refractory hematologic malignancies
NCT02259348Phase 2Terminated
- Sponsor
- St. Jude Children's Research Hospital
- Start
- Oct 2014
- Primary completion
- Apr 2015
- Modality
- Hematopoietic Stem Cells, Native Immune Cells
- Countries
- 1
01
Overview
A Phase 2 trial of CD45RA depleted leukocytes in acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), myeloid sarcoma (MS), chronic myelogenous leukemia (CML), juvenile myelomonocytic leukemia (JMML), sponsored by St. Jude Children's Research Hospital. Started Oct 2014; status: terminated.
02
Drugs
CD45RA depleted leukocytes
03
Conditions
acute lymphoblastic leukemia (ALL)acute myeloid leukemia (AML)myeloid sarcoma (MS)chronic myelogenous leukemia (CML)juvenile myelomonocytic leukemia (JMML)
Beyond the preview
Go deeper on NCT02259348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02259348.